JPS57500783A - - Google Patents

Info

Publication number
JPS57500783A
JPS57500783A JP56501243A JP50124381A JPS57500783A JP S57500783 A JPS57500783 A JP S57500783A JP 56501243 A JP56501243 A JP 56501243A JP 50124381 A JP50124381 A JP 50124381A JP S57500783 A JPS57500783 A JP S57500783A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56501243A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS57500783A publication Critical patent/JPS57500783A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • A61K9/5057Gelatin
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/04Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with macromolecular additives; with layer-forming substances
    • G03C1/047Proteins, e.g. gelatine derivatives; Hydrolysis or extraction products of proteins
    • G03C2001/0471Isoelectric point of gelatine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984Microcapsule with fluid core [includes liposome]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989Microcapsule with solid core [includes liposome]
JP56501243A 1980-04-21 1981-04-15 Pending JPS57500783A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8013003 1980-04-21

Publications (1)

Publication Number Publication Date
JPS57500783A true JPS57500783A (ja) 1982-05-06

Family

ID=10512898

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56501243A Pending JPS57500783A (ja) 1980-04-21 1981-04-15

Country Status (8)

Country Link
US (1) US4442051A (ja)
EP (1) EP0057184A4 (ja)
JP (1) JPS57500783A (ja)
AU (1) AU536032B2 (ja)
CA (1) CA1148862A (ja)
GB (1) GB2075458B (ja)
WO (1) WO1981002976A1 (ja)
ZA (1) ZA812470B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61500432A (ja) * 1982-12-09 1986-03-13 ビルトン,ジエラルド エル. 易吸収性脂肪酸エマルシヨン
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3688188T2 (de) * 1985-12-27 1993-10-14 Sumitomo Pharma Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
SE8604684L (sv) * 1986-11-03 1988-05-04 Excorim Kommanditbolag Sett att belegga fasta partiklar med en hydrofil gel samt genom settet belagda partiklar
US4752470A (en) * 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
FR2663222A1 (fr) * 1990-06-13 1991-12-20 Medgenix Group Sa Microcapsule de liquide huileux.
DE4140191C2 (de) * 1991-12-05 1998-02-19 Alfatec Pharma Gmbh Retardform für ein Indometacin oder Acemetacin enthaltendes Arzneimittel und seine Herstellung
US6974592B2 (en) * 2002-04-11 2005-12-13 Ocean Nutrition Canada Limited Encapsulated agglomeration of microcapsules and method for the preparation thereof
DE60332958D1 (de) * 2002-11-04 2010-07-22 Ocean Nutrition Canada Ltd Mikrokapseln mit mehrfachen hüllen und verfahren zu deren herstellung
WO2008017962A2 (en) * 2006-06-05 2008-02-14 Ocean Nutrition Canada Ltd. Microcapsules with improved shells
EP2124905B1 (en) 2007-01-10 2016-09-07 DSM Nutritional Products AG Microcapsules including pea protein
HU231309B1 (hu) 2014-02-25 2022-11-28 Darholding Kft. Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3495988A (en) * 1968-03-06 1970-02-17 Leslie L Balassa Encapsulation of aromas and flavors
US3549555A (en) * 1968-10-08 1970-12-22 Ncr Co Encapsulation of lipophilic liquid-in-hydrophilic liquid emulsions
US3557279A (en) * 1969-06-12 1971-01-19 Merck & Co Inc Microencapsulation form of an anti-inflammatory drug
NL7112083A (ja) * 1970-09-16 1972-03-20
US4082688A (en) * 1972-12-14 1978-04-04 Ncr Corporation Process for producing microcapsules
JPS5814253B2 (ja) * 1974-04-10 1983-03-18 カンザキセイシ カブシキガイシヤ ビシヨウカプセルノ セイゾウホウホウ

Also Published As

Publication number Publication date
EP0057184A1 (en) 1982-08-11
CA1148862A (en) 1983-06-28
AU536032B2 (en) 1984-04-12
GB2075458B (en) 1983-06-02
EP0057184A4 (en) 1983-06-09
AU7031081A (en) 1981-11-10
ZA812470B (en) 1982-04-28
GB2075458A (en) 1981-11-18
US4442051A (en) 1984-04-10
WO1981002976A1 (en) 1981-10-29

Similar Documents

Publication Publication Date Title
FR2478999B1 (ja)
FR2479241B1 (ja)
FR2484841B1 (ja)
FR2480269B1 (ja)
FR2480599B1 (ja)
FR2479372B1 (ja)
DE3049168C2 (ja)
FR2479021B1 (ja)
FR2475297B1 (ja)
FR2478320B1 (ja)
FR2479376B1 (ja)
DE3042350C2 (ja)
FR2478231B1 (ja)
JPS57500783A (ja)
FR2480314B1 (ja)
FR2474988B1 (ja)
FR2477861B1 (ja)
FR2478143B1 (ja)
FR2480209B1 (ja)
DE3023614C2 (ja)
FR2479248B1 (ja)
FR2477844B2 (ja)
FR2476078B1 (ja)
FR2478712B1 (ja)
FR2477817B1 (ja)